Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Laurence Epstein

Clinical Cardiac Electrophysiology Boston, MA Medical Doctor

NPI 1457318859 CMS profile 156773

75 Francis St, Brigham And Womens Hospital Cardiovascular Division, Boston, MA 02115

Open in the dashboard

General payments

$172,346

177 records reported · program years 2019–2025

Research payments

$3,975

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$757,792 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Laurence Epstein of Boston, MA is reported in the CMS Open Payments database as having received $172,346 across 177 general payments and $3,975 in research payments paid to them. Separately, studies naming them as principal investigator received $757,792 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,651 9
2025 Research $2,100 2
2024 General $4,185 8
2024 Research $1,875 1
2023 General $30,928 34
2022 General $20,509 19
2021 General $26,813 12
2020 General $36,362 19
2019 General $46,899 76

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Laurence Epstein
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Laurence Epstein were reported at $6,651. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Laurence Epstein Clinical Cardiac Electrophysiology median Middle half National median
2019 $46,899 $2,361 $585–$8,260 $163
2020 $36,362 $993 $247–$4,351 $114
2021 $26,813 $1,185 $326–$4,739 $132
2022 $20,509 $2,073 $554–$6,789 $149
2023 $30,928 $2,568 $759–$8,159 $160
2024 $4,185 $2,557 $703–$7,403 $164
2025 $6,651 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $70,367 41 payments
  2. Medtronic, Inc. $43,173 40 payments
  3. Medtronic Vascular, Inc. $31,063 41 payments
  4. Boston Scientific Corporation $12,748 22 payments
  5. Abbott Laboratories $11,791 25 payments
  6. Asahi Intecc Co., Ltd. $1,000 1 payment
  7. Asahi Intecc USA, Inc. $1,000 1 payment
  8. Respicardia, Inc. $833 2 payments
  9. Cordis US Corp. $262 1 payment
  10. Cardiva Medical, Inc. $75 2 payments
  11. Other $35 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $85,888 40 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $70,781 30 payments
  3. Travel and Lodging $12,256 40 payments
  4. Food and Beverage $3,421 67 payments
Products named General payments · program years 2019–2025
  1. (9520) IGT Devices Undivided $36,425 14 payments
  2. Micra Pacemakers $12,709 8 payments
  3. Bridge $11,650 3 payments
  4. MICRA Pacemakers $10,406 24 payments
  5. Spectranetics Undiv $9,836 6 payments
  6. CVX-300 $9,650 2 payments
  7. CardioMEMS HF System $6,690 3 payments
  8. Synergy $6,595 4 payments
  9. Reveal LINQ $3,000 1 payment
  10. General - Therapies $2,718 8 payments
  11. Other $14,293 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $3,975 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

218

Median for Cardiology: 2,533

Drug cost

$67,938

Median for Cardiology: $485,213

Branded share of claims

26.1%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 57 $60,475
Dofetilide Generic 17 $3,757
Amiodarone Hcl Generic 43 $1,789
Metoprolol Succinate Generic 73 $1,074
Flecainide Acetate Generic 28 $843

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$217,577

Medicare's payments for the services billed

Medicare patients

663

Average age 78

Services billed

3,036

285 women, 378 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 63%
Atrial fibrillation 60%
Heart failure 55%
Arthritis 54%
Diabetes 51%
Chronic kidney disease 40%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record